Table 2.
Publication bias assessment by Egger’s statistical test for effect of vitamin D supplementation on the levels of 25(OH)D, CB 25(OH)D, hs-CRP, MDA, TAC and GSH
| Markers | NO of interventions | NO of participants | Coefficient | Std. Err | t | P | 95% CI | |
|---|---|---|---|---|---|---|---|---|
| LL | UL | |||||||
| 25(OH)D | 15 | 1061 | 7.56 | 1.33 | 5.65 | < 0.001 | 4.67 | 10.45 |
| CB 25(OH)D | 3 | 162 | 12.06 | 32.81 | 0.37 | 0.77 | -404.05 | 429.05 |
| hs-CRP | 11 | 670 | 6.05 | 4.63 | 1.31 | 0.22 | -4.42 | 16.53 |
| TAC | 9 | 543 | 15.35 | 1.32 | 11.63 | < 0.001 | 12.23 | 18.47 |
| MDA | 6 | 370 | -21.99 | 3.32 | 6.62 | 0.003 | -31.21 | -12.77 |
| GSH | 9 | 539 | 12.73 | 1.30 | 9.78 | < 0.001 | 9.65 | 15.81 |
Abbreviations: 25(OH)D 25-hydroxyvitamin D3, CB Cord Blood, CI Confidence interval, hs-CRP High-sensitivity C-reactive protein, TAC Total antioxidant capacity, MDA Malondialdehyde, GSH Glutathione